Maternal steatotic liver disease and offspring neurodevelopmental disorders: a nationwide cohort study
This nationwide Korean cohort study of over 778,000 mother-child pairs found that maternal metabolic dysfunction-associated steatotic liver disease (MASLD) prior to pregnancy showed only a modest, likely attenuated association with offspring attention-deficit/hyperactivity disorder (ADHD) and no significant link to autism spectrum disorder or intellectual disability.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The health of a mother before she becomes pregnant is increasingly understood as a powerful force shaping her child's future, particularly the development of the brain. Scientists have long known that conditions like obesity, diabetes, and high blood pressure can influence how a child's nervous system grows, sometimes leading to lifelong challenges in learning, attention, or social interaction. These conditions often cluster together, creating a state of metabolic stress that affects the entire body. One specific manifestation of this stress is a condition where fat builds up in the liver, not due to heavy drinking, but because of the body's struggle to process sugar and fat. This liver condition, now recognized as a common chronic disease worldwide, serves as a visible sign that the body's metabolic engine is running poorly. Researchers have begun to wonder if this specific liver issue, present before conception, might leave a mark on the developing brain of the child, potentially increasing the risk for disorders such as autism, intellectual disability, or attention-deficit/hyperactivity disorder.
To answer this question, a team of researchers in South Korea conducted a massive study involving nearly 780,000 mother-child pairs. They utilized a unique national health system that covers almost the entire population, allowing them to link detailed medical records from mothers with the long-term health outcomes of their children. The researchers first identified mothers who had undergone a standard health checkup within two years before becoming pregnant. Using data from these checkups, such as waist size, blood pressure, and blood sugar levels, they categorized the mothers into three groups: those with a healthy liver, those with the non-alcoholic fatty liver condition, and those with liver issues related to alcohol consumption. They then followed the children born to these mothers for up to twelve years, tracking whether they were diagnosed with intellectual disability, autism spectrum disorder, or attention-deficit/hyperactivity disorder. The goal was to see if the mother's liver health before pregnancy predicted these outcomes, even after accounting for other factors like income, smoking, and pre-existing health conditions.
The results of this enormous investigation revealed a picture that was more complex than a simple cause-and-effect relationship. When the researchers looked at the raw numbers, children born to mothers with the fatty liver condition appeared to have higher rates of all three neurodevelopmental disorders compared to children of healthy mothers. However, once the scientists adjusted for the many other health and lifestyle factors that often travel together with fatty liver disease—such as high blood pressure, diabetes, and obesity—the strong links to intellectual disability and autism disappeared. In the final analysis, there was no clear evidence that the mother's fatty liver condition directly caused these two specific disorders. The data suggested that the initial connection was likely due to the broader metabolic health of the mother rather than the liver condition itself.
The story was slightly different for attention-deficit/hyperactivity disorder. After adjusting for all the other factors, a small but noticeable link remained between the mother's fatty liver condition and the child developing this disorder. Children of mothers with this condition were slightly more likely to receive a diagnosis of attention-deficit/hyperactivity disorder than children of healthy mothers. However, the researchers found that this link was fragile. When they applied a stricter definition of the disorder, requiring multiple medical visits to confirm the diagnosis rather than just a single record, the connection weakened and became statistically insignificant. This suggests that while there may be a very small association, it is not a strong or definitive one. For the group of mothers with liver issues related to alcohol, the study found no statistically significant link to any of the neurodevelopmental outcomes, though the number of children in this group was too small to draw firm conclusions.
The researchers emphasize that their findings should be viewed as a starting point for further inquiry rather than a final verdict. The study was designed to generate hypotheses about how maternal liver health might interact with child development, but it cannot prove that one causes the other. The small size of the remaining link for attention-deficit/hyperactivity disorder means that unmeasured factors, such as genetics or family environment, could still be playing a role. The study also had limitations, such as relying on health checkups that occurred up to two years before pregnancy, which might not perfectly reflect the mother's health at the exact moment of conception. Furthermore, the definitions of the liver conditions were based on blood tests and measurements rather than direct imaging of the liver. Despite these constraints, the study provides a clear boundary for what we currently know: a mother's fatty liver condition before pregnancy does not appear to be a major driver of autism or intellectual disability in her children, and any connection to attention-deficit/hyperactivity disorder is likely to be very small and sensitive to how the condition is defined. This clarity helps scientists focus future research on the most promising areas, ensuring that medical understanding moves forward on a solid foundation of evidence.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.